NHLBI Awards $14.4M for Five-year Study of Hypertrophic Cardiomyopathy | GenomeWeb

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute has awarded a consortium of institutions $14.4 million to research better methods of predicting which hypertrophic cardiomyopathy patients are at the highest risk of heart failure or sudden death.

The University of Virginia School of Medicine and the University of Oxford in the UK, will direct the five-year study which will follow 2,750 patients for up to five years. The study will be conducted at 35 to 40 sites in the US, Canada, and Europe, including the UK, Italy and Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.